Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 Prevalence.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
13 05 2020
Historique:
received: 21 04 2020
revised: 11 05 2020
accepted: 12 05 2020
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 9 10 2020
Statut: epublish

Résumé

We aim to validate a case-finding algorithm to detect individuals with multiple sclerosis (MS) using routinely collected healthcare data, and to assess the prevalence of MS in the Campania Region (South Italy). To identify individuals with MS living in the Campania Region, we employed an algorithm using different routinely collected healthcare administrative databases (hospital discharges, drug prescriptions, outpatient consultations with payment exemptions), from 1 January 2015 to 31 December 2017. The algorithm was validated towards the clinical registry from the largest regional MS centre (n = 1460). We used the direct method to standardise the prevalence rate and the capture-recapture method to estimate the proportion of undetected cases. The case-finding algorithm including individuals with at least one MS record during the study period captured 5362 MS patients (females = 64.4%; age = 44.6 ± 12.9 years), with 99.0% sensitivity (95% CI = 98.3%, 99.4%). Standardised prevalence rate per 100,000 people was 89.8 (95% CI = 87.4, 92.2) (111.8 for females [95% CI = 108.1, 115.6] and 66.2 for males [95% CI = 63.2, 69.2]). The number of expected MS cases was 2.7% higher than cases we detected. We developed a case-finding algorithm for MS using routinely collected healthcare data from the Campania Region, which was validated towards a clinical dataset, with high sensitivity and low proportion of undetected cases. Our prevalence estimates are in line with those reported by international studies conducted using similar methods. In the future, this cohort could be used for studies with high granularity of clinical, environmental, healthcare resource utilisation, and pharmacoeconomic variables.

Identifiants

pubmed: 32414017
pii: ijerph17103388
doi: 10.3390/ijerph17103388
pmc: PMC7277756
pii:
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2019 Sep 19;14(9):e0222012
pubmed: 31536513
Front Neurol. 2019 Jan 10;9:1150
pubmed: 30687214
Health Policy. 2020 Jan;124(1):69-74
pubmed: 31812325
J Neurol Sci. 2019 Mar 15;398:163-170
pubmed: 30731303
Neuroepidemiology. 2019;52(1-2):41-46
pubmed: 30476909
Neurodegener Dis Manag. 2015;5(6 Suppl):55-8
pubmed: 26611275
Neurology. 2019 Mar 5;92(10):e1029-e1040
pubmed: 30770430
Neurol Sci. 2019 Jan;40(1):155-165
pubmed: 30426289
N Engl J Med. 2017 Apr 27;376(17):1615-1626
pubmed: 28445677
JAMA Neurol. 2020 May 4;:
pubmed: 32364569
J Neurol. 2016 Apr;263(4):751-9
pubmed: 26886201
Lancet Neurol. 2019 Mar;18(3):269-285
pubmed: 30679040
Mult Scler Relat Disord. 2019 Jan;27:171-178
pubmed: 30384204
Neurol Sci. 2020 May;41(5):1089-1095
pubmed: 31872352
Neurology. 2016 Mar 15;86(11):1014-21
pubmed: 26888980
Mult Scler. 2016 Nov;22(13):1642-1648
pubmed: 27270498
Epidemiol Prev. 2019 Jul-Aug;43(4 Suppl 2):62-74
pubmed: 31650807
Nat Rev Neurol. 2018 Feb;14(2):75-93
pubmed: 29326424
Lancet. 2018 Apr 21;391(10130):1622-1636
pubmed: 29576504
Epidemiol Rev. 1995;17(2):243-64
pubmed: 8654510
Biom J. 2020 Jan 20;:
pubmed: 31957128
Stat Med. 1984 Jul-Sep;3(3):287-91
pubmed: 6484378
Nat Rev Neurol. 2017 Feb;13(2):105-118
pubmed: 28084327
Neurology. 2019 Mar 5;92(10):e1016-e1028
pubmed: 30770432
Neuroepidemiology. 2016;46(1):37-42
pubmed: 26618996
Ann Neurol. 2018 Jun;83(6):1162-1173
pubmed: 29740872
Mult Scler J Exp Transl Clin. 2019 Dec 18;5(4):2055217319896090
pubmed: 31903222
Am J Epidemiol. 1995 Nov 15;142(10):1059-68
pubmed: 7485051
Phys Ther. 2005 Mar;85(3):257-68
pubmed: 15733050
Mult Scler. 2015 Sep;21(10):1244-50
pubmed: 25583850
Neurol Sci. 2017 Mar;38(3):473-479
pubmed: 28040843
Mult Scler. 2019 Apr;25(5):627-636
pubmed: 30351211
Mult Scler. 2012 Sep;18(9):1244-50
pubmed: 22354740
Pharmacoeconomics. 1999 Jul;16(1):1-8
pubmed: 10539118
Mult Scler. 2020 Jan;26(1):23-37
pubmed: 31778094
Neurol Sci. 2020 Feb;41(2):397-402
pubmed: 31691867
Ther Adv Neurol Disord. 2019 Feb 18;12:1756286418819074
pubmed: 30815035
Environ Res. 2020 Mar;182:109022
pubmed: 31883496
Mult Scler. 2016 Apr;22(5):659-67
pubmed: 26362896
BMC Health Serv Res. 2014 Sep 10;14:381
pubmed: 25209585
Am J Epidemiol. 1995 Nov 15;142(10):1047-58
pubmed: 7485050
Mult Scler Relat Disord. 2018 Jan;19:50-54
pubmed: 29128737
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
BMJ. 2018 Nov 27;363:k4674
pubmed: 30482751
Mult Scler. 2017 Jul;23(8):1123-1136
pubmed: 28273775

Auteurs

Marcello Moccia (M)

Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.

Vincenzo Brescia Morra (V)

Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.

Roberta Lanzillo (R)

Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.

Ilaria Loperto (I)

Department of Public Health, Federico II University, 80131 Naples, Italy.

Roberta Giordana (R)

Campania Region Healthcare System Commissioner Office, 80131 Naples, Italy.

Maria Grazia Fumo (MG)

Regional Healthcare Society (So.Re.Sa), 80131 Naples, Italy.

Martina Petruzzo (M)

Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.

Nicola Capasso (N)

Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy.

Maria Triassi (M)

Department of Public Health, Federico II University, 80131 Naples, Italy.

Maria Pia Sormani (MP)

Biostatistics Unit, Department of Health Sciences, University of Genoa, 16121 Genoa, Italy.

Raffaele Palladino (R)

Department of Public Health, Federico II University, 80131 Naples, Italy.
Department of Primary Care and Public Health, Imperial College, London SW7 2AZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH